Company: PharmaEssentia CorporationBloomberg ticker: 6446 TTMarket cap: US$7,259mBackground: PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer. The company was founded in 2003 by a group of Taiwanese-American executives and scientists from American biotech and pharmaceutical companies.
World Class Benchmarking of PharmaEssentia Corp
(Click on image to enlarge)
More By This Author:Asian Stock: Jiangsu Hengrui PharmaceuticalsAsian Stock: Zhejiang China Commodities City GroupAsian Stock: President Chain Store Corp
